Detail page

Knowledge Web

Person

Stefan Lichtenthaler

Chemiker

Name	Stefan Lichtenthaler
Time	1998- (Wirkungsdaten)
Place	Deutschland
Academic degree	Prof. Dr.
Profession	Chemiker (characteristic profession) Molekularbiologe
Variant	Stefan F. Lichtenthaler
Related	Technische Universität München. Lehrstuhl für Proteomik (2012 -) Universität Heidelberg. Zentrum für Molekulare Biologie (1998)
Further information	Promotion an der Univ. Heidelberg, 1998
Source	Homepage. Gesehen am 10.03.2016: http://www.synergy-munich.de/members/investigators/lichtenthaler/cv/index.html
Record type	Person
GND-Identifier	1024551288
Record ID	1024551288
Involved in show all Soluble form of Lingo2, an autism spectrum disorder-associated molecule, functions as an excitatory synapse organizer in neurons Loss of CLN3 in microglia leads to impaired lipid metabolism and myelin turnover Rational correction of pathogenic conformational defects in HTRA1 Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis How substrate helix dynamics affect intramembrane proteolysis by γ-secretase. Investigating the uptake and accumulation of Tau monomers and aggregates in human neurons Author Correction: Spatial proteomics reveals secretory pathway disturbances caused by neuropathy-associated TECPR2 Reactivated endogenous retroviruses promote protein aggregate spreading The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130 Spatial proteomics reveals secretory pathway disturbances caused by neuropathy-associated TECPR2 Microtubule-associated protein tau gene as risk factor for the sporadic Parkinson syndrome : a postmortem brain study in Parkinson's disease and control Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion Study of alpha-synuclein fragments and their involvement in spreading of pathology: New insights for immunotherapies Amyloid-beta mediates homeostatic synaptic plasticity An optimized quantitative proteomics method establishes the cell type‐resolved mouse brain secretome Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3 Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1 Untersuchung der biochemischen Eigenschaften und der Substratspaltung der Alzheimer-Protease ADAM10 (neu) Tau deletion reduces plaque‐associated BACE 1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease Signal peptide peptidase‐like 2c impairs vesicular transport and cleaves SNARE proteins Signal peptide peptidase‐like 2c impairs vesicular transport and cleaves SNARE proteins The intramembrane protease SPPL 2c promotes male germ cell development by cleaving phospholamban Nr CAM is a marker for substrate‐selective activation of ADAM 10 in Alzheimer's disease Function and substrates of the Alzheimer´s disease protease BACE1 Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP The intramembrane protease SPPL2c promotes male germ cell development by cleaving phospholamban Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments Non‐cell‐autonomous function of DR6 in Schwann cell proliferation Proteolytic ectodomain shedding of membrane proteins in mammals - hardware, concepts, and recent developments Proteolytische Spaltung der Transmembranproteine PTPRN2, PLXDC2 und ENPP5 durch die Alzheimer-Protease BACE1 Bepridil and amiodarone simultaneously target the Alzheimer's disease beta- and gamma-secretase via distinct mechanisms

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Stefan Lichtenthaler

Soluble form of Lingo2, an autism spectrum disorder-associated molecule, functions as an excitatory synapse organizer in neurons

Loss of CLN3 in microglia leads to impaired lipid metabolism and myelin turnover

Rational correction of pathogenic conformational defects in HTRA1

Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis

How substrate helix dynamics affect intramembrane proteolysis by γ-secretase.

Investigating the uptake and accumulation of Tau monomers and aggregates in human neurons

Author Correction: Spatial proteomics reveals secretory pathway disturbances caused by neuropathy-associated TECPR2

Reactivated endogenous retroviruses promote protein aggregate spreading

The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130

Spatial proteomics reveals secretory pathway disturbances caused by neuropathy-associated TECPR2

Microtubule-associated protein tau gene as risk factor for the sporadic Parkinson syndrome : a postmortem brain study in Parkinson's disease and control

Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae

Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity

ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion

Study of alpha-synuclein fragments and their involvement in spreading of pathology: New insights for immunotherapies

Amyloid-beta mediates homeostatic synaptic plasticity

An optimized quantitative proteomics method establishes the cell type‐resolved mouse brain secretome

Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3

Mouse brain proteomics establishes MDGA1 and CACHD1 as in vivo substrates of the Alzheimer protease BACE1

Untersuchung der biochemischen Eigenschaften und der Substratspaltung der Alzheimer-Protease ADAM10 (neu)

Tau deletion reduces plaque‐associated BACE 1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease

Signal peptide peptidase‐like 2c impairs vesicular transport and cleaves SNARE proteins

Signal peptide peptidase‐like 2c impairs vesicular transport and cleaves SNARE proteins

The intramembrane protease SPPL 2c promotes male germ cell development by cleaving phospholamban

Nr CAM is a marker for substrate‐selective activation of ADAM 10 in Alzheimer's disease

Function and substrates of the Alzheimer´s disease protease BACE1

Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP

The intramembrane protease SPPL2c promotes male germ cell development by cleaving phospholamban

Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments

Non‐cell‐autonomous function of DR6 in Schwann cell proliferation

Proteolytic ectodomain shedding of membrane proteins in mammals - hardware, concepts, and recent developments

Proteolytische Spaltung der Transmembranproteine PTPRN2, PLXDC2 und ENPP5 durch die Alzheimer-Protease BACE1

Bepridil and amiodarone simultaneously target the Alzheimer's disease beta- and gamma-secretase via distinct mechanisms